SMi's masterclass hosted by PAREXEL International will discuss ADCs which are being tested in the clinic in a range of oncology indications. In the absence of specific guidance on the development of ADCs, this workshop aims to help participants understand the CMC issues during the development, with a particular focus on the assessment and control of the quality of such products. Benefits of Attending • Identify key parameters for non-clinical studies to support a Phase 1 clinical trial • Consider the factors that influence the choice of conjugate and linker types • Learn how to create an early phase product development plan that meets regulatory expectations • Network with and learn from senior industry representatives Contact Fateja Begum Tel: +44 (0) 20 7827 6184